Nature killer cell therapies catch up to CAR-T

From The Scientist, 1 April 2020: When the first anticancer therapies based on engineered T cells hit the market a few years ago, they offered the possibility of what would have once been perceived as a medical miracle: a one-shot cure for certain blood cancers. Chimeric antigen receptor (CAR) T cell therapies, as they are Continue reading Nature killer cell therapies catch up to CAR-T